Preventive Effects of Green Tea (Camellia Sinensis var. Assamica) on Diabetic Nephropathy
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to evaluate the preventive effects of Camellia sinensis var. assamica (CSVA) on diabetic nephropathy in in vitro and in vivo models. Materials and Methods: MDCK cells were incubated with 1 mM of oxalate with or without different concentrations of CSVA, then MTT and malondialdehyde (MDA) assays were performed to investigate the preventive effects of CSVA on oxalate-induced cytotoxicity and oxidative stress. Thirty male db/db mice were divided into three groups. Group 1 were fed AIN-93G ad libitum; group 2 were fed AIN-93G mixed with 10% fermented CSVA ad libitum; group 3 were fed AIN-93G mixed with 10% non-fermented CSVA ad libitum. The mice were sacrificed 14 weeks later, and the serum glucose level, 24-hour urine chemistry, and morphological changes in the kidneys were examined. Results: As CSVA concentrations increased,viable MDCK cells increased in concentration. MDA production decreased over time in the CSVA treated group. The creatinine clearance of group 3 was lower than those of groups 1 and 2. The amount of urine microalbumin and protein in group 1 were higher than those in groups 2 and 3. Also, more glomerulus basement membrane foot processes were preserved in groups 2 and 3. Conclusion:In conclusion, CSVA has beneficial preventive tendencies towards diabetic nephropathy in both in vitro and in vivo models.
Abstract
Purpose: This study aimed to evaluate the preventive effects of Camellia sinensis var. assamica (CSVA) on diabetic nephropathy in in vitro and in vivo models. Materials and Methods: MDCK cells were incubated with 1 mM of oxalate with or without different concentrations of CSVA, then MTT and malondialdehyde (MDA) assays were performed to investigate the preventive effects of CSVA on oxalate-induced cytotoxicity and oxidative stress. Thirty male db/db mice were divided into three groups. Group 1 were fed AIN-93G ad libitum; group 2 were fed AIN-93G mixed with 10% fermented CSVA ad libitum; group 3 were fed AIN-93G mixed with 10% non-fermented CSVA ad libitum. The mice were sacrificed 14 weeks later, and the serum glucose level, 24-hour urine chemistry, and morphological changes in the kidneys were examined. Results: As CSVA concentrations increased,viable MDCK cells increased in concentration. MDA production decreased over time in the CSVA treated group. The creatinine clearance of group 3 was lower than those of groups 1 and 2. The amount of urine microalbumin and protein in group 1 were higher than those in groups 2 and 3. Also, more glomerulus basement membrane foot processes were preserved in groups 2 and 3. Conclusion:In conclusion, CSVA has beneficial preventive tendencies towards diabetic nephropathy in both in vitro and in vivo models.
참고문헌 (23)
- Soldatos G, "Diabetic nephropathy: important pathophysiologic mechanisms", Diabetes Res Clin Pract, 82, pp.75~79 (2008)
- Giunti S, "Diabetic nephropathy: from mechanisms to rational therapies", Minerva Med, 97, pp.241~262 (2006)
- Renno WM, "Effect of green tea on kidney tubules of diabetic rats", Br J Nutr, 100, pp.652~659 (2008)
- Cabrera C, "Beneficial effects of green tea--a review", J Am Coll Nutr, 25, pp.79~99 (2006)
- Crespy V, "A review of the health effects of green tea catechins in in vivo animal models", J Nutr, 134, pp.3431~3440 (2004)
- 손규목, "녹차와 보이차 추출물의 항산화 효과", 한국식품영양학회지, 18(3), pp.219~224 (2005), 한국식품영양학회
- Thielecke F, "The potential role of green tea catechins in the prevention of the metabolic syndrome - a review", Phytochemistry, 70, pp.11~24 (2009)
- Wong SH, "Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct", Clin Chem, 33, pp.214~220 (1987)
- Unger J., "Diagnosis and management of type 2 diabetes and prediabetes", Prim Care, 34, pp.731~759 (2007)
- The Diabetes Control and Complications Trial Research Group, "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus", N Engl J Med, 329, pp.977~986 (1993)
- Chang HY, "Use of complementary and alternative medicine among people living with diabetes: literature review", J Adv Nurs, 58, pp.307~319 (2007)
- Ryu OH, "Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients", DIABETES RES CLIN PRACT, 71, pp.356~358
- Chan EWC, "Antioxidant activity of Camellia sinensis leaves and tea from a lowland plantation in Malaysia", Food Chem, 102, pp.1214~1222 (2007)
- Jeong BC, "Effects of green tea on urinary stone formation: an in vivo and in vitro study", J Endourol, 20, pp.356~361 (2006)
- Igarashi K, "Effects of dietary catechins on glucose tolerance, blood pressure and oxidative status in Goto-Kakizaki rats", J Nutr Sci Vitaminol (Tokyo), 53, pp.496~500 (2007)
- Yamabe N, "Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats", J Pharmacol Exp Ther, 319, pp.228~236 (2006)
- Yokozawa T, "Green tea polyphenols and dietary fibre protect against kidney damage in rats with diabetic nephropathy", J Pharm Pharmacol, 57, pp.773~780 (2005)
- Christiansen JS, "Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics", Diabetologia, 20, pp.451~456 (1981)
- Zatz R, "Pathogenesis of diabetic microangiopathy. The hemodynamic view", Am J Med, 80, pp.443~453 (1986)
- Li JJ, "Podocyte biology in diabetic nephropathy", Kidney Int Suppl, pp.S36~S42 (2007)
- Guo Q, "Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes", Biochim Biophys Acta, 1304, pp.210~222 (1996)
- Zaveri NT, "Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications", Life Sci, 78, pp.2073~2080 (2006)
- Tu YY, "The changes of catechins during the fermentation of green tea", Prikl Biokhim Mikrobiol, 41, pp.652~655 (2005)